US 10730941
Antigen-binding proteins targeting CD56 and uses thereof
granted A61KA61K2039/505A61K2239/31
Quick answer
US patent 10730941 (Antigen-binding proteins targeting CD56 and uses thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Aug 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 36
- CPC classes
- A61K, A61K2039/505, A61K2239/31, A61K2239/38, A61K2239/48